Screener

Income Tax Expense Benefit

Name: Gyre Therapeutics, Inc. Income Tax Expense Benefit by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Gyre Therapeutics, Inc.·Business Segments·2 segments·Rolls up to Income Tax

Breakdown

Segment	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Gyre Pharmaceuticals	$1.07M	$201K	$901K	$662K	$1.69M	$1.3M	$621K	-$165K
Gyre	$500	$500	$0	-$0	$2K	$0	$0	$1K
Total	$1.07M	$203K	$901K	$662K	$1.69M	$1.3M	$621K	-$164K

Segments

Gyre PharmaceuticalsView metric

GyreView metric